Crystallization of three key glycolytic enzymes of the opportunistic pathogen Cryptosporidium parvum

Olga Senkovich1, Haley Speed, Alexei Grigorian

  • 1Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, AL-35294, USA.

Insights

Researchers studied key energy-producing enzymes in Cryptosporidium parvum, a cause of waterborne illness. Structural analysis of these enzymes may reveal differences between the parasite and humans, aiding drug development.

Area of Science:

  • Biochemistry
  • Parasitology
  • Structural Biology

Background:

  • Cryptosporidium parvum is a significant cause of global waterborne diseases.
  • This protozoan parasite relies on anaerobic glucose metabolism for energy.
  • Understanding structural differences in parasitic enzymes compared to human hosts is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the three-dimensional structures of key glycolytic enzymes in Cryptosporidium parvum.
  • To identify structural distinctions between C. parvum enzymes and their human host counterparts.
  • To provide a structural basis for developing targeted anti-parasitic agents.

Main Methods:

  • Expression and purification of recombinant glyceraldehyde 3-phosphate dehydrogenase, pyruvate kinase, and lactate dehydrogenase from C. parvum.
  • Crystallization of these enzymes in apo-form and, for lactate dehydrogenase, in the presence of substrates and cofactors.
  • Collection of X-ray diffraction data for all crystallized enzyme forms.

Main Results:

  • Recombinant versions of three key glycolytic enzymes were successfully produced and crystallized.
  • Lactate dehydrogenase was crystallized in multiple states, offering insights into its conformational flexibility.
  • X-ray diffraction data were obtained, paving the way for detailed structural determination.

Conclusions:

  • The structural characterization of C. parvum glycolytic enzymes has been initiated.
  • These structural insights are vital for understanding parasite metabolism and host-pathogen interactions.
  • The identified structural differences can inform the design of novel therapeutics against cryptosporidiosis.